Status:
COMPLETED
Effect of Intracameral Injection of Mydriatic Plus Anaesthetic Combination on Corneal Endothelial Count in Phaco
Lead Sponsor:
Cairo University
Conditions:
Corneal Endothelial Cell Loss
Mydriasis
Eligibility:
All Genders
60-75 years
Phase:
PHASE3
Brief Summary
Study evaluates safety of intracameral injection of Fydrane (tropicamide 0.02%, phenylephrine 0.31% and lidocaine 1%) on corneal endothelium, and efficiency in maintaining pupillary dilatation during ...
Detailed Description
in this prospective randomized controlled study, 30 eyes of 30 patients undergoing phacoemulsification with intraocular lens (IOL) implantation, were assigned into 2 groups. 15 eyes (Fydrane group) re...
Eligibility Criteria
Inclusion
- medium density cataract (nuclear II to III)
Exclusion
- soft or hard density cataract (nuclear I or IV)
- history of ocular trauma or previous intraocular surgery
- iatrogenic, congenital or traumatic cataract
- associated eye disease e.g. pseudoexofoliation syndrome
- associated pre-existing corneal endothelial disease e.g. Fuchs dystrophy
- associated systemic disease that can affect endothelium,
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04396301
Start Date
February 1 2019
End Date
September 30 2019
Last Update
May 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University - Kasr Alainy hospital
Cairo, Egypt